96 related articles for article (PubMed ID: 9014525)
1. Hearing anomalies following radiation therapy for head and neck cancers.
Varghese G; Sahota JS; Hazarika P; Rajashekar B
Indian J Exp Biol; 1996 Sep; 34(9):878-9. PubMed ID: 9014525
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
Pan CC; Eisbruch A; Lee JS; Snorrason RM; Ten Haken RK; Kileny PR
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1393-402. PubMed ID: 15817342
[TBL] [Abstract][Full Text] [Related]
3. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
4. Sensori-neural hearing loss following radiotherapy to the nasopharynx.
Moretti JA
Laryngoscope; 1976 Apr; 86(4):598-602. PubMed ID: 1263730
[TBL] [Abstract][Full Text] [Related]
5. A prospective study on radiation-induced changes in hearing function.
Herrmann F; Dörr W; Müller R; Herrmann T
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1338-44. PubMed ID: 16863923
[TBL] [Abstract][Full Text] [Related]
6. [Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors].
Altmann S; Hoffmanns H
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():30-3. PubMed ID: 10584138
[TBL] [Abstract][Full Text] [Related]
7. [Tolerance of normal tissues to radiation therapy: ear].
Fleury B; Lapeyre M
Cancer Radiother; 2010 Jul; 14(4-5):284-9. PubMed ID: 20605506
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors.
Zuur CL; Simis YJ; Lamers EA; Hart AA; Dreschler WA; Balm AJ; Rasch CR
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):490-6. PubMed ID: 19135315
[TBL] [Abstract][Full Text] [Related]
9. Sensorineural hearing loss after radiotherapy for head and neck tumors: a prospective study of the effect of radiation.
Yilmaz YF; Aytas FI; Akdogan O; Sari K; Savas ZG; Titiz A; Tumoz M; Unal A
Otol Neurotol; 2008 Jun; 29(4):461-3. PubMed ID: 18520582
[TBL] [Abstract][Full Text] [Related]
10. Effects of cranial irradiation on hearing acuity: a review of the literature.
Sataloff RT; Rosen DC
Am J Otol; 1994 Nov; 15(6):772-80. PubMed ID: 8572091
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
[TBL] [Abstract][Full Text] [Related]
12. Ototoxicity after radiotherapy for head and neck tumors.
Bhandare N; Antonelli PJ; Morris CG; Malayapa RS; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):469-79. PubMed ID: 17236969
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in radiotherapy for head and neck cancers.
Chou RH; Wilder RB; Wong MS; Forster KM
Ear Nose Throat J; 2001 Oct; 80(10):704-7, 711-4, 716 passim. PubMed ID: 11605568
[TBL] [Abstract][Full Text] [Related]
14. Radiation treatment breaks and ulcerative mucositis in head and neck cancer.
Russo G; Haddad R; Posner M; Machtay M
Oncologist; 2008 Aug; 13(8):886-98. PubMed ID: 18701763
[TBL] [Abstract][Full Text] [Related]
15. Taste dysfunction in irradiated patients with head and neck cancer.
Zheng WK; Inokuchi A; Yamamoto T; Komiyama S
Fukuoka Igaku Zasshi; 2002 Apr; 93(4):64-76. PubMed ID: 12048909
[TBL] [Abstract][Full Text] [Related]
16. Hypothyroidism after radiotherapy for patients with head and neck cancer.
Ozawa H; Saitou H; Mizutari K; Takata Y; Ogawa K
Am J Otolaryngol; 2007; 28(1):46-9. PubMed ID: 17162132
[TBL] [Abstract][Full Text] [Related]
17. Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.
Zuur CL; Simis YJ; Verkaik RS; Schornagel JH; Balm AJ; Dreschler WA; Rasch CR
Radiother Oncol; 2008 Oct; 89(1):38-43. PubMed ID: 18706728
[TBL] [Abstract][Full Text] [Related]
18. Management of oral health in patients irradiated for head and neck cancer: a review.
Shenoy VK; Shenoy KK; Rodrigues S; Shetty P
Kathmandu Univ Med J (KUMJ); 2007; 5(1):117-20. PubMed ID: 18604001
[TBL] [Abstract][Full Text] [Related]
19. Aerosol orgotein (Ontosein) for the prevention of radiotherapy-induced adverse effects in head and neck cancer patients: a feasibility study.
Escribano A; García-Grande A; Montañés P; Miralles L; García A
Neoplasma; 2002; 49(3):201-8. PubMed ID: 12098008
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiation therapy in head and neck cancers: an update.
Lee N; Puri DR; Blanco AI; Chao KS
Head Neck; 2007 Apr; 29(4):387-400. PubMed ID: 16358297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
